| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/10/2008 | US7384756 Methods for treating muscle diseases and disorders |
| 06/10/2008 | US7384655 Preparation of compositions to alleviate inflammation and oxidative stress in a mammal |
| 06/10/2008 | US7384653 Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
| 06/10/2008 | US7384651 Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience |
| 06/10/2008 | US7384631 Contacting myeloid cells in a sample with a ligand directed against p75/AIRM1(75 kd adhesion inhibitory receptor molecule1) receptor, and determining binding of the ligand |
| 06/10/2008 | US7384418 Methods and devices for delivery of agents to breast milk ducts |
| 06/10/2008 | CA2369070C 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof |
| 06/10/2008 | CA2341814C Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues |
| 06/10/2008 | CA2329768C Pharmaceutical composition comprising factor viii and neutral liposomes |
| 06/10/2008 | CA2311530C Nasal solutions |
| 06/10/2008 | CA2302586C Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 06/10/2008 | CA2252584C Treatment of carcinomas using squalamine in combination with other anti-cancer agents |
| 06/10/2008 | CA2230730C Microemulsions for use as vehicles for administration of active compounds |
| 06/05/2008 | WO2008066854A2 Methods and compositions for inducing apoptosis in cancer cells |
| 06/05/2008 | WO2008066064A1 Regulation of the activity of transcriptional factor stat by zinc ion |
| 06/05/2008 | WO2008065738A1 Bone defect filler, release-controlled carrier, and their production methods |
| 06/05/2008 | WO2008065726A1 Telomelysin-containing agent for breaking antitumor tolerance |
| 06/05/2008 | WO2008065409A2 Combination for use in the treatment of cancer, comprising tamoxifen or an aromatase inhibitor |
| 06/05/2008 | WO2008065397A2 Assay |
| 06/05/2008 | US20080132963 Method and apparatus for treating tumors using low strength electric fields |
| 06/05/2008 | US20080132587 Low Peak Exotherm Curable Compositions |
| 06/05/2008 | US20080132585 Separate type medical material |
| 06/05/2008 | US20080132574 Leukotriene B4 receptor binding activity; treatment of skin disease such as psoriasis, eczema, skin cancer, keratosis, dyspigmentation or psilosis |
| 06/05/2008 | US20080132541 immunomodulatory compound is administered in combination with a therapy conventionally used to treat, prevent or manage cancer; potent inhibition of TNF- alpha but also marked inhibition of LPS |
| 06/05/2008 | US20080132512 Combination of Brimonidine and Timolol for Topical Ophthalmic Use |
| 06/05/2008 | US20080132473 Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology |
| 06/05/2008 | US20080132472 Compounds for the treatment of psychiatric or substance abuse disorders |
| 06/05/2008 | US20080131976 Novel G protein coupled receptor protein, DNA its ligand |
| 06/05/2008 | US20080131889 Novel human genes and gene expression products: II |
| 06/05/2008 | US20080131524 Compositions for treatment of viral-induced skin lesions and methods of using same |
| 06/05/2008 | US20080131494 Dermal Penetration enhancers and drug delivery systems involving same |
| 06/05/2008 | US20080131486 Biocompatible intraocular implants include a steroid and a polymer associated with each other to facilitate release of the steroid into an eye for a period of time greater than about two months. The steroid mmatrix of a two biodegradable polymer matrix |
| 06/05/2008 | US20080131466 Glucopyranosyl lipid adjuvant; toll-like receptors; saponins; kits |
| 06/05/2008 | US20080131458 Vaccine Adjuvants |
| 06/05/2008 | US20080131438 Antibodies to non-functional p2x7 receptor |
| 06/05/2008 | US20080131407 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 06/05/2008 | DE102006058183A1 Verwendung von Substanzen, die den zellulären Glutathion-Gehalt absenken, zur Herstellung eines Arzneimittels zur Behandlung von T-Zell vermittelten Autoimmunkrankheiten Use of substances which lower the cellular glutathione content, to prepare a medicament for the treatment of T cell mediated autoimmune diseases |
| 06/05/2008 | DE102006056766A1 Verwendung von kompatiblen Soluten Use of compatible solutes |
| 06/05/2008 | CA2673483A1 Compositions of chk1 inhibitors |
| 06/05/2008 | CA2670587A1 Assay |
| 06/05/2008 | CA2669184A1 Method of diagnosing and treating glioma |
| 06/04/2008 | EP1927362A2 Alphavbeta3integrin as a predictor of endometriosis |
| 06/04/2008 | EP1927354A1 Novel substituted benzimidazole dosage forms and method of using same |
| 06/04/2008 | EP1927350A1 Methods for improving bioavailability of a renin inhibitor |
| 06/04/2008 | EP1927348A1 Anticonvulsive pharmaceutical compositions |
| 06/04/2008 | EP1926490A2 Use of opioid receptor antagonists |
| 06/04/2008 | EP1926483A2 Treatment of autoimmune diseases |
| 06/04/2008 | EP1926477A1 Composition comprising a nsaid and paracetamol |
| 06/04/2008 | EP1493033B1 Use of sc6 for diagnosis and treatment of breast carcinoma |
| 06/04/2008 | EP1448089A4 Devices and methods for the restoration of a spinal disc |
| 06/04/2008 | EP1365781B1 Acrochordon alleviation |
| 06/04/2008 | EP1354951B1 Method of examining ability to control nerve cell plasticity |
| 06/04/2008 | EP1137436B1 Stimulation of T-cells against self antigens using CTLA-4 blocking agents |
| 06/04/2008 | EP1019082B2 Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 06/04/2008 | EP0958305B1 Inhibitions of the interaction between p53 and mdm2 |
| 06/04/2008 | CN101194017A Conjugate comprising p21 protein for the treatment of cancer |
| 06/04/2008 | CN101193682A Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an antiparasitic agent, and an active agent selected among carveol, thymol, eugenol, borneol and carvacrol |
| 06/04/2008 | CN101193656A Novel triglyceride reducing agent |
| 06/04/2008 | CN101190237A Anti-cold drugs containing dexibuprofen |
| 06/04/2008 | CN100392074C Dendritic cell tumor vaccine and its preparation and use |
| 06/04/2008 | CN100391977C Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 06/04/2008 | CN100391958C Chemical compounds |
| 06/04/2008 | CN100391542C Composition for delivering genes to antigen presenting cells of the skin and its use |
| 06/04/2008 | CN100391538C Ectocornea extension promoters |
| 06/04/2008 | CN100391537C Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B |
| 06/04/2008 | CN100391534C Modulation of smooth muscle cell proliferation |
| 06/04/2008 | CN100391470C Antithrombogenic platiniferous ceramic composition and article containing the same |
| 06/04/2008 | CN100391469C Remedies for hepatitis C |
| 06/04/2008 | CN100391462C Enhanced drug delivery in transdermal systems |
| 06/04/2008 | CN100391461C Hypotensive lipid and timolol compositions and methods of using same |
| 06/04/2008 | CN100391437C GM-CSF targeted medicine liposome for resisting acute myelogenous leukemia and preparation method thereof |
| 06/03/2008 | US7381807 Of given nucleotide sequence; encapsulated in slow release delivery vehicle; includes viral or bacterial antigen; increases cell proliferation, differentiation, cytokine and antibody production for lymphocytes |
| 06/03/2008 | US7381790 Copolymers for suppression of autoimmune diseases, and methods of use |
| 06/03/2008 | US7381751 Mixture of silicone resin with chelate compound, pigemnt and lubricant; molding |
| 06/03/2008 | US7381747 3-Aminomethyl-5-methyl-octanoic acid; antidepressant and anxiolytic agent; obsessive compulsive disorder (OCD), agoraphobia, agoraphobia without history of panic disorder, specific phobia, social phobia, restless legs syndrome, premenstrual dysphoric disorder, hot flashes, and fibromyalgia; not addictive |
| 06/03/2008 | US7381744 inhibit intra-organellar acidification of intracellular organelles; activity in the plasma membranes of kidney intercalated cells, osteoclasts and sperm cells; urinary acidification, bone resorption, or the acrosomal acid secretion required for fertility, adjuncts to cancer therapy |
| 06/03/2008 | US7381740 Melatonin analogue prodrugs |
| 06/03/2008 | US7381731 Pharmaceutical composition comprising citrulline |
| 06/03/2008 | US7381713 Treatment of cancer by reduction of intracellular energy and pyrimidines |
| 06/03/2008 | US7381710 Nucleic acid comprising a sequence encoding promyelocytic leukemia retinoic acid receptor alpha and a non-immunosuppressive inducer of tumor cell apoptosis which is arsenic; all-trans, 9-cis or 13-cis retinoic acid; or 4 allopurinol-l-ribonucleoside |
| 06/03/2008 | US7381704 Methods for use of short bioactive peptides |
| 06/03/2008 | US7381699 Reagents and methods for smooth muscle therapies |
| 06/03/2008 | US7381560 Administering a chimeric anti-CD20 antibody; hybridomas; monoclonal antibodies |
| 06/03/2008 | US7381422 Mixing cationic surfactant, a polyoxyethylene and polyoxypropylene block copolymer and a polynucleotide at a temperature below the cloud point of said block copolymer to form a mixture; cold filtering the mixture to produce a sterile formulation |
| 06/03/2008 | US7381412 Monoclonal antibody for use in diagnosis, prevention and treatment of inflammatory disorders |
| 06/03/2008 | US7381404 Treatment for dry macular degeneration |
| 06/03/2008 | CA2501587C Solid preparation having phase containing insulin sensitizer and another active ingredient uniformly mixed |
| 06/03/2008 | CA2467964C Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 06/03/2008 | CA2368186C Use of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 06/03/2008 | CA2339628C Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome |
| 06/03/2008 | CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/03/2008 | CA2279846C Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 06/03/2008 | CA2269919C Skin vibration method for topical targeted delivery of beneficial agents into hair follicles |
| 06/03/2008 | CA2261018C Treatment and diagnosis of cancer |
| 06/03/2008 | CA2244664C Composition comprising interleukin-1 inhibitor and controlled release polymer |
| 05/29/2008 | WO2008063943A2 Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain |
| 05/29/2008 | WO2008063603A2 Methods, compositions, and kits for treating pain and pruritis |
| 05/29/2008 | WO2008062066A1 Methods for improving bioavailability of a renin inhibitor |
| 05/29/2008 | WO2008062040A1 Anticonvulsive pharmaceutical compositions |
| 05/29/2008 | WO2008061373A1 Combination treatments for alzheimer's disease and similar diseases |